Page last updated: 2024-08-23

lovastatin and Carcinoma, Lewis Lung

lovastatin has been researched along with Carcinoma, Lewis Lung in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ho, BY; Pan, TM	1
Dabrowska, A; Feleszko, W; Giermasz, A; Gołab, J; Jakóbisiak, M; Jalili, A; Kozłowska, E; Maj, M; Makowski, M; Nowis, D; Wójcik, C	1

Other Studies

2 other study(ies) available for lovastatin and Carcinoma, Lewis Lung

Article	Year
The Monascus metabolite monacolin K reduces tumor progression and metastasis of Lewis lung carcinoma cells. Journal of agricultural and food chemistry, 2009, Sep-23, Volume: 57, Issue:18 Topics: Animals; Carcinoma, Lewis Lung; Fermentation; Lovastatin; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Monascus; Neoplasm Metastasis; Oryza; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A	2009
Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice. International journal of cancer, 2002, Feb-20, Volume: 97, Issue:6 Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Lewis Lung; Cell Cycle; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Synergism; Drug Therapy, Combination; Female; Flow Cytometry; Formazans; Lovastatin; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Tetrazolium Salts; Triglycerides; Tumor Suppressor Protein p53	2002

Article

Year

The Monascus metabolite monacolin K reduces tumor progression and metastasis of Lewis lung carcinoma cells.

Journal of agricultural and food chemistry, 2009, Sep-23, Volume: 57, Issue:18

Topics: Animals; Carcinoma, Lewis Lung; Fermentation; Lovastatin; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Monascus; Neoplasm Metastasis; Oryza; Plant Extracts; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A

2009

Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice.

International journal of cancer, 2002, Feb-20, Volume: 97, Issue:6

Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Lewis Lung; Cell Cycle; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Synergism; Drug Therapy, Combination; Female; Flow Cytometry; Formazans; Lovastatin; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Tetrazolium Salts; Triglycerides; Tumor Suppressor Protein p53

2002